Skip to main content

Advanced Search

Haematologica
  • Home
  • Current Issue
  • Ahead Of Print
  • Archive
  • Submit a Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Submit a Manuscript
    • Track a Manuscript
  • About Us
    • About Haematologica
    • Editorial Board
    • Our Policies
  • More
    • Advertising
    • Rights & Permissions
    • Alerts
    • Feedback
    • Contact
Clinical efficacy of ruxolitinib and chemotherapy in a child with Philadelphia chromosome-like acute lymphoblastic leukemia with GOLGA5-JAK2 fusion and induction failure
Yang Y. Ding, Julie W. Stern, Tracey F. Jubelirer, Gerald B. Wertheim, Fumin Lin, Fengqi Chang, Zhaohui Gu, Charles G. Mullighan, Yong Li, Richard C. Harvey, I-Ming Chen, Cheryl L. Willman, Stephen P. Hunger, Marilyn M. Li, Sarah K. Tasian
Haematologica September 2018 103: e427-e431; doi:10.3324/haematol.2018.192088
Yang Y. Ding
Children’s Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA University of Pennsylvania Perelman School of Medicine, Department of Pediatrics, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie W. Stern
Children’s Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA University of Pennsylvania Perelman School of Medicine, Department of Pediatrics, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tracey F. Jubelirer
Children’s Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA University of Pennsylvania Perelman School of Medicine, Department of Pediatrics, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerald B. Wertheim
University of Pennsylvania Perelman School of Medicine, Department of Pathology and Laboratory, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fumin Lin
Children’s Hospital of Philadelphia, Division of Genomic Diagnostics Medicine; Children’s Hospital of Philadelphia, Division of Hematopathology PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fengqi Chang
Children’s Hospital of Philadelphia, Division of Genomic Diagnostics Medicine; Children’s Hospital of Philadelphia, Division of Hematopathology PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhaohui Gu
St Jude Children’s Research Hospital, Department of Pathology, Memphis, TN, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles G. Mullighan
St Jude Children’s Research Hospital, Department of Pathology, Memphis, TN, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yong Li
Children’s Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard C. Harvey
University of New Mexico, Department of Pathology and Hematologic Malignancies Research Program, Albuquerque, NM, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I-Ming Chen
University of New Mexico, Department of Pathology and Hematologic Malignancies Research Program, Albuquerque, NM, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cheryl L. Willman
University of New Mexico, Department of Pathology and Hematologic Malignancies Research Program, Albuquerque, NM, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen P. Hunger
Children’s Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA University of Pennsylvania Perelman School of Medicine, Department of Pediatrics, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marilyn M. Li
Children’s Hospital of Philadelphia, Division of Genomic Diagnostics Medicine; Children’s Hospital of Philadelphia, Division of Hematopathology PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah K. Tasian
Children’s Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA University of Pennsylvania Perelman School of Medicine, Department of Pediatrics, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tasians@email.chop.edu

Author Affiliations

  1. Yang Y. Ding1,2,
  2. Julie W. Stern1,2,
  3. Tracey F. Jubelirer1,2,
  4. Gerald B. Wertheim3,
  5. Fumin Lin4,
  6. Fengqi Chang4,
  7. Zhaohui Gu5,
  8. Charles G. Mullighan5,
  9. Yong Li1,
  10. Richard C. Harvey6,
  11. I-Ming Chen6,
  12. Cheryl L. Willman6,
  13. Stephen P. Hunger1,2,
  14. Marilyn M. Li4 and
  15. Sarah K. Tasian1,2⇑
  1. 1Children’s Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA
  2. 2University of Pennsylvania Perelman School of Medicine, Department of Pediatrics, PA, USA
  3. 3University of Pennsylvania Perelman School of Medicine, Department of Pathology and Laboratory, PA, USA
  4. 4Children’s Hospital of Philadelphia, Division of Genomic Diagnostics Medicine; Children’s Hospital of Philadelphia, Division of Hematopathology PA, USA
  5. 5St Jude Children’s Research Hospital, Department of Pathology, Memphis, TN, USA
  6. 6University of New Mexico, Department of Pathology and Hematologic Malignancies Research Program, Albuquerque, NM, USA
  1. Correspondence: tasians{at}email.chop.edu
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 103 no. 9 e427-e431
DOI 
https://doi.org/10.3324/haematol.2018.192088
PubMed 
29773603

Published By 
Haematologica
Print ISSN 
0390-6078
Online ISSN 
1592-8721

History 

    Article Versions

    • previous version (May 17, 2018 - 01:37).
    • You are viewing the most recent version of this article.
    Copyright & Usage 
    Copyright © 2018 Ferrata Storti Foundation

    Author Information

    1. Yang Y. Ding1,2,
    2. Julie W. Stern1,2,
    3. Tracey F. Jubelirer1,2,
    4. Gerald B. Wertheim3,
    5. Fumin Lin4,
    6. Fengqi Chang4,
    7. Zhaohui Gu5,
    8. Charles G. Mullighan5,
    9. Yong Li1,
    10. Richard C. Harvey6,
    11. I-Ming Chen6,
    12. Cheryl L. Willman6,
    13. Stephen P. Hunger1,2,
    14. Marilyn M. Li4 and
    15. Sarah K. Tasian1,2⇑
    1. 1Children’s Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, PA, USA
    2. 2University of Pennsylvania Perelman School of Medicine, Department of Pediatrics, PA, USA
    3. 3University of Pennsylvania Perelman School of Medicine, Department of Pathology and Laboratory, PA, USA
    4. 4Children’s Hospital of Philadelphia, Division of Genomic Diagnostics Medicine; Children’s Hospital of Philadelphia, Division of Hematopathology PA, USA
    5. 5St Jude Children’s Research Hospital, Department of Pathology, Memphis, TN, USA
    6. 6University of New Mexico, Department of Pathology and Hematologic Malignancies Research Program, Albuquerque, NM, USA
    1. Correspondence: tasians{at}email.chop.edu

    Statistics from Altmetric.com

    Article usage

    Article usage: May 2018 to January 2019

    AbstractFullPdf
    May 2018239097
    Jun 2018196071
    Jul 201880079
    Aug 201874589
    Sep 201810222155
    Oct 201897970
    Nov 201886164
    Dec 201835325
    Jan 2019193324
    PreviousNext
    Back to top

    Vol 103 Issue 9

    Haematologica: 103 (9)
    • Table of Contents
    • Table of Contents (PDF)
    • About the Cover
    • Index by author
    Email

    Thank you for your interest in spreading the word about Haematologica.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Clinical efficacy of ruxolitinib and chemotherapy in a child with Philadelphia chromosome-like acute lymphoblastic leukemia with GOLGA5-JAK2 fusion and induction failure
    (Your Name) has forwarded a page to you from Haematologica
    (Your Name) thought you would like to see this page from the Haematologica web site.
    Print
    Citation Tools
    Clinical efficacy of ruxolitinib and chemotherapy in a child with Philadelphia chromosome-like acute lymphoblastic leukemia with GOLGA5-JAK2 fusion and induction failure
    Yang Y. Ding, Julie W. Stern, Tracey F. Jubelirer, Gerald B. Wertheim, Fumin Lin, Fengqi Chang, Zhaohui Gu, Charles G. Mullighan, Yong Li, Richard C. Harvey, I-Ming Chen, Cheryl L. Willman, Stephen P. Hunger, Marilyn M. Li, Sarah K. Tasian
    Haematologica Sep 2018, 103 (9) e427-e431; DOI: 10.3324/haematol.2018.192088

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Yang Y. Ding, Julie W. Stern, Tracey F. Jubelirer, Gerald B. Wertheim, Fumin Lin, Fengqi Chang, Zhaohui Gu, Charles G. Mullighan, Yong Li, Richard C. Harvey, I-Ming Chen, Cheryl L. Willman, Stephen P. Hunger, Marilyn M. Li, Sarah K. Tasian
    Haematologica Sep 2018, 103 (9) e427-e431; DOI: 10.3324/haematol.2018.192088
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Alert me when this article is cited
    • Alert me if a correction is posted

    Jump To

    • Article
      • Acknowledgments
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • PDF

    More in this TOC Section

    • Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study
    • Continuous high dosing of lenalidomide in relapsed, refractory or older newly diagnosed acute myeloid leukemia patients not suitable for other treatment options - results from a phase I study
    • Endothelial protein C receptor (EPCR) expression marks human fetal liver hematopoietic stem cells
    Show more Online Only Articles

    Related Articles

    Cited By...

    What about you?
    Tell us your interests and get all the new contents of Haematologica in advance

     

     

    Navigate

    • Home
    • Current issue
    • Ahead of print
    • Archive
    • Info for
      • Authors
      • Reviewers
      • Advertisers
      • Subscribers
    • About us
      • About Haematologica
      • Editorial Board
      • Our policies

    For Authors

    • Author guidelines
    • Submit Manuscript
    • Track Manuscript

    For Reviewers

    • Reviewer Guidelines
    • Access Your Profile
    • Access Your Tasks
    • 2014 reviewers

    For Advertisers

    • Information For Advertising

    Education

    • Review Articles
    • Guideline Articles

    More

    • Rights & Permissions
    • Advertising
    • Alerts
    • Feedback
    • Contact
    • App

    Copyright © 2019 by the Ferrata Storti Foundation

    ISSN 0390-6078 print

    ISSN 1592-8721 online